{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T09:07:16Z","timestamp":1789549636875,"version":"build-2803163510"},"reference-count":23,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med. Sci.","Medical Sciences"],"abstract":"<jats:p>Background: Patients with atrial fibrillation (AF) receiving direct oral anticoagulants (DOAC) are at an elevated risk of gastrointestinal (GI) mucosal damage and bleeding. Proton pump inhibitors (PPI) are conventional gastroprotectors, but their efficacy in the lower GI tract is limited. This study evaluated the efficacy and safety of rebamipide monotherapy and combination pantoprazole-rebamipide (P + R) therapy compared to pantoprazole monotherapy in this vulnerable population. Methods: In the randomized, parallel-group, open-label, single-center REGATA trial, 210 AF patients receiving DOAC were randomized (1:1:1) to three gastroprotective regimens (n = 70 each) for 24 weeks: pantoprazole monotherapy, rebamipide monotherapy, or their combination. Efficacy analyses were performed in the per-protocol population (n = 118: pantoprazole, n = 36; rebamipide, n = 39; P + R, n = 43). The primary and secondary outcomes included composite clinical GI events (bleeding classified by ISTH\/BARC, ulcers\/erosions, and severe dyspepsia) and biomarkers of mucosal barrier function (fecal zonulin and calprotectin). Results: The incidence of primary efficacy endpoint events was 13.9% (n = 5; 95% CI: 3.1\u201325.7) in the pantoprazole group, 10.3% (n = 4; 95% CI: 2.3\u201321.1) in the rebamipide group, and 9.3% (n = 4; 95% CI: 2.1\u201318.6) in the P + R group, successfully confirming the non-inferiority hypothesis for both experimental arms within the pre-specified margin of 10% (p &lt; 0.05). Multivariable regression analysis showed that compared with pantoprazole monotherapy, rebamipide monotherapy demonstrated an odds ratio OR of 0.71 (95% CI: 0.18\u20132.88, p = 0.630), while the P + R therapy was associated with an OR of 0.64 (95% CI: 0.16\u20132.57, p = 0.525). No major GI bleeding events or fatalities occurred; a single episode of GI bleeding (ISTH minor\/BARC Type 2) was recorded in the pantoprazole arm (2.8%). Fecal calprotectin levels significantly decreased in the rebamipide group (by 37.6%, from 139 to 78 \u00b5g\/g; p &lt; 0.001) and the P + R group (by 50.0%, from 135 to 61 \u00b5g\/g; p &lt; 0.001), while no significant changes were observed in the pantoprazole group (p = 0.530). Concurrently, fecal zonulin levels, reflecting intestinal epithelial permeability, fell by 45.1% in the rebamipide arm (from 434 to 225 ng\/mL; p &lt; 0.001) and by 47.1% in the P + R arm (from 347 to 182 ng\/mL; p &lt; 0.001) compared to a minimal 3.0% fluctuation in the pantoprazole group. Conclusions: While demonstrating non-inferiority regarding primary clinical endpoints, both rebamipide monotherapy and combination (P + R) therapy achieved some advantages over pantoprazole monotherapy in decreasing subclinical GI inflammation and restoring intestinal epithelial barrier integrity.<\/jats:p>","DOI":"10.3390\/medsci14050565","type":"journal-article","created":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:19:41Z","timestamp":1789381181000},"page":"565","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative Efficacy of Rebamipide, Pantoprazole, and Their Combination for Gastroprotection in Patients with Atrial Fibrillation Receiving Direct Oral Anticoagulants: The Randomized REGATA Study"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6021-7864","authenticated-orcid":false,"given":"Natalya M.","family":"Vorobyeva","sequence":"first","affiliation":[{"name":"Russian Gerontology Clinical and Research Center, Pirogov Russian National Research Medical University, 1st Leonova Street, 16, 129226 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5964-5725","authenticated-orcid":false,"given":"Irina P.","family":"Malaya","sequence":"additional","affiliation":[{"name":"Russian Gerontology Clinical and Research Center, Pirogov Russian National Research Medical University, 1st Leonova Street, 16, 129226 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4027-3727","authenticated-orcid":false,"given":"Vadim D.","family":"Zakiev","sequence":"additional","affiliation":[{"name":"Russian Gerontology Clinical and Research Center, Pirogov Russian National Research Medical University, 1st Leonova Street, 16, 129226 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5720-2663","authenticated-orcid":false,"given":"Antonina A.","family":"Masharova","sequence":"additional","affiliation":[{"name":"Russian Gerontology Clinical and Research Center, Pirogov Russian National Research Medical University, 1st Leonova Street, 16, 129226 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7928-598X","authenticated-orcid":false,"given":"Tatiana P.","family":"Pinchuk","sequence":"additional","affiliation":[{"name":"Russian Gerontology Clinical and Research Center, Pirogov Russian National Research Medical University, 1st Leonova Street, 16, 129226 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5090-585X","authenticated-orcid":false,"given":"Irina V.","family":"Kostomarova","sequence":"additional","affiliation":[{"name":"Russian Gerontology Clinical and Research Center, Pirogov Russian National Research Medical University, 1st Leonova Street, 16, 129226 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1222-3351","authenticated-orcid":false,"given":"Valentina S.","family":"Ostapenko","sequence":"additional","affiliation":[{"name":"Russian Gerontology Clinical and Research Center, Pirogov Russian National Research Medical University, 1st Leonova Street, 16, 129226 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1628-5093","authenticated-orcid":false,"given":"Yulia V.","family":"Kotovskaya","sequence":"additional","affiliation":[{"name":"Russian Gerontology Clinical and Research Center, Pirogov Russian National Research Medical University, 1st Leonova Street, 16, 129226 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4193-688X","authenticated-orcid":false,"given":"Olga N.","family":"Tkacheva","sequence":"additional","affiliation":[{"name":"Russian Gerontology Clinical and Research Center, Pirogov Russian National Research Medical University, 1st Leonova Street, 16, 129226 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,12]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1053\/j.gastro.2013.02.041","article-title":"New oral anticoagulants increase risk for gastrointestinal bleeding: A systematic review and meta-analysis","volume":"145","author":"Holster","year":"2013","journal-title":"Gastroenterology"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: A meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Xu, S., Duan, L., Zhang, Y., Wu, L., Jin, S., and Ma, L. (2026). Temporal trends and disparities in US mortality with co-listed atrial fibrillation and gastrointestinal bleeding-related mortality, 1999\u20132020. BMC Cardiovasc. Disord., 26.","DOI":"10.1186\/s12872-025-05483-0"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1954","DOI":"10.3748\/wjg.v23.i11.1954","article-title":"Gastrointestinal bleeding in patients on novel oral anticoagulants: Risk, prevention and management","volume":"23","author":"Cheung","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/290159a0","article-title":"Substituted benzimidazoles inhibit gastric acid secretion by blocking (H+ + K+)ATPase","volume":"290","author":"Fellenius","year":"1981","journal-title":"Nature"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1053\/j.gastro.2015.05.002","article-title":"Prevention of Dabigatran-Related Gastrointestinal Bleeding with Gastroprotective Agents: A Population-Based Study","volume":"149","author":"Chan","year":"2015","journal-title":"Gastroenterology"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"7123607","DOI":"10.1155\/2018\/7123607","article-title":"Difference between the Upper and the Lower Gastrointestinal Bleeding in Patients Taking Nonvitamin K Oral Anticoagulants","volume":"2018","author":"Maruyama","year":"2018","journal-title":"BioMed Res. Int."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1080\/00365521.2018.1541478","article-title":"Effect of gastroprotective agents on upper gastrointestinal bleeding in patients receiving direct oral anticoagulants","volume":"53","author":"Youn","year":"2018","journal-title":"Scand. J. Gastroenterol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/ueg2.12448","article-title":"Impact of proton pump inhibitors on the risk of small bowel or colorectal bleeding: A systematic review and meta-analysis","volume":"11","author":"Jung","year":"2023","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1177\/10600280251337209","article-title":"Association of Direct Oral Anticoagulant-Proton Pump Inhibitor Co-Therapy with Adverse Outcomes: A Population-Based Cohort Study","volume":"60","author":"Wang","year":"2026","journal-title":"Ann. Pharmacother."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Maev, I.V., Khurmatullina, A.R., Andreev, D.N., Zaborovsky, A.V., Kucheryavyy, Y.A., Sokolov, P.S., and Beliy, P.A. (2026). Rebamipide as an Adjunctive Therapy for Gastrointestinal Diseases: An Umbrella Review. Pharmaceuticals, 19.","DOI":"10.3390\/ph19010144"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2036.2006.02774.x","article-title":"Validation of a 7-point Global Overall Symptom scale to measure the severity of dyspepsia symptoms in clinical trials","volume":"23","author":"Chiba","year":"2006","journal-title":"Aliment. Pharmacol. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1572-0241.1998.00327.x","article-title":"An endoscopic comparison of gastroduodenal injury with over-the-counter doses of ketoprofen and acetaminophen","volume":"93","author":"Lanza","year":"1998","journal-title":"Am. J. Gastroenterol."},{"key":"ref_14","first-page":"23","article-title":"Experts consensus on reducing the risk of gastrointestinal bleeding in patients receiving oral anticoagulants","volume":"10","author":"Lazebnik","year":"2021","journal-title":"Therapy"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ajg.2020.09.007","article-title":"The effect of PPI Alone, PPI plus cytoprotective agent, and H2RA plus cytoprotective agent on ulcer healing after endoscopic submucosal dissection: A prospective randomized controlled trial","volume":"22","author":"Lee","year":"2021","journal-title":"Arab. J. Gastroenterol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/ar4177","article-title":"The use of proton pump inhibitors in treating and preventing NSAID-induced mucosal damage","volume":"15","author":"Scheiman","year":"2013","journal-title":"Arthritis Res. Ther."},{"key":"ref_17","first-page":"1037","article-title":"Severe gastrointestinal bleeding in patients with atrial fibrillation receiving oral anticoagulants (based on REGistry of long-term AnTithrombotic TherApy\u2014REGATTA)","volume":"93","author":"Kropacheva","year":"2021","journal-title":"Ter. Arkhiv"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1007\/s10620-013-2606-0","article-title":"Rebamipide helps defend against nonsteroidal anti-inflammatory drugs induced gastroenteropathy: A systematic review and meta-analysis","volume":"58","author":"Zhang","year":"2013","journal-title":"Dig. Dis. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/pace.14896","article-title":"Fecal calprotectin: A novel predictor of ulcerated esophageal injury after atrial fibrillation catheter ablation","volume":"47","author":"Wang","year":"2024","journal-title":"Pacing Clin. Electrophysiol."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Bl\u00f6baum, L., Witkowski, M., Wegner, M., Lammel, S., Schencke, P.A., Jakobs, K., Puccini, M., Rei\u00dfner, D., Steffens, D., and Landmesser, U. (2023). Intestinal Barrier Dysfunction and Microbial Translocation in Patients with First-Diagnosed Atrial Fibrillation. Biomedicines, 11.","DOI":"10.3390\/biomedicines11010176"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Nenna, A., Laudisio, A., Taffon, C., Fogolari, M., Spadaccio, C., Ferrisi, C., Loreni, F., Giacinto, O., Mastroianni, C., and Barbato, R. (2024). Intestinal Microbiota and Derived Metabolites in Myocardial Fibrosis and Postoperative Atrial Fibrillation. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25116037"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3164\/jcbn.16-49","article-title":"Determination of the adequate dosage of rebamipide, a gastric mucoprotective drug, to prevent low-dose aspirin-induced gastrointestinal mucosal injury","volume":"59","author":"Ota","year":"2016","journal-title":"J. Clin. Biochem. Nutr."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Kovaleva, A., Poluektova, E., Maslennikov, R., Karchevskaya, A., Shifrin, O., Kiryukhin, A., Tertychnyy, A., Kovalev, L., Kovaleva, M., and Lobanova, O. (2023). Effect of Rebamipide on the Intestinal Barrier, Gut Microbiota Structure and Function, and Symptom Severity Associated with Irritable Bowel Syndrome and Functional Dyspepsia Overlap: A Randomized Controlled Trial. J. Clin. Med., 12.","DOI":"10.3390\/jcm12186064"}],"container-title":["Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3271\/14\/5\/565\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T08:34:41Z","timestamp":1789547681000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3271\/14\/5\/565"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,12]]},"references-count":23,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,9]]}},"alternative-id":["medsci14050565"],"URL":"https:\/\/doi.org\/10.3390\/medsci14050565","relation":{},"ISSN":["2076-3271"],"issn-type":[{"value":"2076-3271","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,12]]}}}